Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers

NCT01108120 is registered in ClinicalTrials.gov with Xiang Guang-da as lead sponsor.

NCT NCT01108120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01108120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Therapeutical Role of Continuous Intra-femoral Artery Infusion of Urokinase on Diabetic Foot Ulcers
Lead sponsor
Xiang Guang-da
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
December 30, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer